摘要
Abstract
Objective To observe the clinical efficacy of betahistine mesilate and nimodipine in the treatment of nervous tinni-tus. Methods 68 patients with nervous tinnitus in the hospital from December 2013 to December 2014 were divided into the treatment group and the control group,34 cases each. The control group was treated with nimodipine,while the treatment group used the betahis-tine mesilate therapy. Results The tinnitus symptom after treatment in the two groups was effectively improved,moreover the improve-ment of the treatment group was more significant( P < 0. 05);the scores of tinnitus symptom in the treatment group were significantly lower than those in the control group( P < 0. 05);the effective elicitation rate of transient evoked otoacoustic emission(TEOAE)in the treatment group was significantly higher than that in the control group;the adverse reactions appeared during the treatment process in the two groups,but the occurrence rate of adverse reaction in the treatment group was significantly lower than that in the control group,the difference was statistically significant( P < 0. 05). Conclusion Betahistine mesilate has definite clinical effect for treating nervous tinnitus,can promote the recovery of cochlear function with high safety and deserves to be clinically promoted.关键词
甲磺酸倍他司汀/神经性耳鸣/瞬态诱发性耳声发射Key words
betahistine mesilate/tinnitus/transient evoked otoacoustic emission分类
医药卫生
